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The genetic manipulation of Mycobacterium tuberculosis genome is limited by the
availability of selection markers. Spontaneous resistance mutation rate of
M. tuberculosis to the widely used kanamycin is relatively high which often leads
to some false positive transformants. Due to the few available markers, we have
created a cassette containing thiostrepton resistance gene (tsr) for selection in
M. tuberculosis and M. bovis BCG, and gentamicin resistance gene (aacC1) for
Escherichia coli and M. smegmatis mc2155, flanked with dif sequences recognized by
the Xer system of mycobacteria. This cassette adds to the limited available selection
markers for mycobacteria.
Keywords: mycobacteria, selection marker, thiostrepton, gentamicin
INTRODUCTION
Gene manipulation in mycobacteria is performed using a limited number of selection markers.
Mycobacteria are naturally resistant to many antibiotics and requires use of stable drugs with low
frequency of spontaneous resistance for selection, hence limiting the alternative choices (Parish and
Brown, 2008). The combined use of multiple markers enables more versatile genetic modifications,
including the stable maintenance of multiple plasmids and inactivation of multiple genes (Wada
et al., 2016).
Aminoglycoside phosphotransferase (aph) genes, conferring resistance to kanamycin (KAN),
were the first to be used as selection markers in mycobacteria (Snapper et al., 1988) owing to their
stability over the extended periods of incubation for slow-growing mycobacteria. However, their
utility is limited by emergence of spontaneous resistance, albeit at low frequencies (Hatfull, 1996).
Unlike fast-growing bacteria, slow-growing mycobacteria have a single rRNA operon (Suzuki et al.,
1987) which is more prone to mutations conferring resistance to agents such as KAN (Bottger,
1994). Besides, selection using KAN in Mycobacterium w and Mycobacterium vaccae has not been
achieved. Radford and Hodgson (1991) first reported the use of hygromycin (HYG) resistance gene
(hyg) as a selection marker in M. smegmatis and M. bovis BCG in 1991. Since then, it has been
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used in other mycobacteria. The use of hyg provides a marker
gene which does not provide cross resistance to clinically useful
drugs (Garbe et al., 1994). It offers an improved transformation
frequency over KAN and is probably more efficiently expressed
in mycobacteria than the Escherichia coli-derived aminoglycoside
phosphotransferase genes conferring KAN resistance (Garbe
et al., 1994). The use of apramycin as a selection marker in
both slow- and fast-growing mycobacteria was first reported
by Paget and Davies in 1996, following its disapproval for
clinical use in humans. However, its utility is limited by the
acetylation of other closely related aminoglycoside such as
KAN (Davies and O‘Connor, 1978; Consaul and Pavelka, 2004),
and low transformation efficiencies. β-lactam-based selection
markers such as the ampicillin resistance gene ampr are
not useful in mycobacteria since they contain endogenous
β-lactamases that confers natural resistance to penicillins
(Hatfull, 1996).
Other past explorations have included resistance to
chloramphenicol (Das Gupta et al., 1993), but have been
limited due to poor stability and high rates of spontaneous
mutations, hence unsuitable for slow-growing mycobacteria.
Streptomycin, sulfonamide (Gormley and Davies, 1991) and
mercury salts (Baulard et al., 1995) have also been explored as
possible selectable markers, but to date, KAN, HYG, and GEN
resistance genes remain the often widely exploited selectable
markers in mycobacterial genetics.
Owing to the limited number of markers and their
disadvantages, we hence sought to explore use of methyl-
accepting chemotaxis protein I, a serine sensor receptor tsr
gene conferring resistance to thiostrepton (TSR), as a selectable
marker in M. tuberculosis and M. bovis BCG. TSR, a thiazole
antibiotic, was first isolated and characterized from Streptomyces
azureus (Cundliffe, 1971) in 1954 at the Squibb Institute (Pagano
et al., 1956) and is used in veterinary medicine to treat mastitis,
and as a topical agent for dogs. However, it has only found limited
applications due to its poor solubility and toxicity (Kuiper and
Conn, 2014).
Thiostrepton inhibits protein translation by firmly binding to
the complex formed by 23S rRNA and ribosomal protein L11 in
bacterial ribosomes (Cannon and Burns, 1971; Cundliffe, 1971).
The tsr gene encodes an RNA methyltransferase that prevents
TSR from binding to ribosomes by 23S rRNA methylation
(Thompson et al., 1982). The tsr confer total resistance to TSR
and thus has been the selection marker of choice in many of the
Streptomyces spp. cloning vectors (Thompson et al., 1980).
In a recent study on ovarian cancer cell lines, Westhoff et al.
(2014) demonstrated that when TSR is used in combination
with the standard paclitaxel/cisplatin chemotherapy, it decreases
Forkhead box M1 (FOXM1) gene expression besides showing
an enhanced synergistic cytotoxicity in ascites cells from
platinum-resistant patients. In addition, Wada et al. (2016)
also demonstrated tsr as a viable selection marker for the
thermophilic Geobacillus kaustophilus besides demonstrating
accurate selection as a single copy in Streptomyces strains.
However, only scanty data showed that TSR is active against
M. tuberculosis (Vermeulen and Wu, 2004; Lougheed et al., 2009)
in drug testing.
MATERIALS AND METHODS
Strains, Media, and Culture Conditions
Escherichia coli DH5α was grown at 37◦C in Luria-Bertani
(LB) broth and agar. M. tuberculosis H37Rv, autoluminescent
M. tuberculosis H37Ra (Yang et al., 2015), M. bovis BCG
Tice and M. smegmatis mc2155 and their recombinants were
grown in Middle Brook 7H9 broth (Becton Dickinson, USA)
supplemented with 10% oleic acid albumin dextrose catalase
(OADC, Becton Dickinson) and 0.05% tween80, or on solid
Middle Brook 7H11 medium (Difco) supplemented with 10%
OADC. On agar plates,M. tuberculosisH37Rv,M. bovis BCG Tice
and M. avium were incubated for 4–5 weeks, and M. abscessus
GZ002 and M. smegmatis mc2155 were incubated for 3–4 days
in 37◦C.
Thiostrepton and GEN were purchased from Sigma–Aldrich
(China) and dissolved in dimethyl sulfoxide (DMSO) and double
distilled water, respectively. GEN 20 and 5 µg/mL was used
for selection of E. coli and M. smegmatis mc2155, respectively,
and TSR 5 and 10 µg/mL of both M. tuberculosis H37Rv and
M. bovis BCG Tice. LB broth was augmented with 170 µg/mL
chloramphenicol Sigma–Aldrich (China).
Drug Susceptibility Testing
We first tested the potential of TSR as a selection antibiotic
for M. tuberculosis up to a final concentration of 10 µg/mL in
liquid culture of autoluminescent M. tuberculosis H37Ra (AUlRa)
(Table 1) as previously described (Zhang et al., 2012). Briefly,
2 mL of AUlRa was inoculated in 50 mL 7H9 plus OADC and
tween80 with shaking at 37◦C to mid log phase (OD600= 0.6–0.8)
in a flask and then diluted to appropriate concentrations. Drugs
(5 µL/drug) were added into the 1.5 mL vial, mixed with 195 µL
AUlRa and incubated at 37◦C. Controls using 195 µL AUlRa and
DMSO (5 µL) or 195 µL AUlRa and water (5 µL) tubes were
included. Relative light measurements (RLUs) were monitored
starting day 0, day 1, day 3, and day 5 using GloMax 20/20
Luminometer (Promega).
Susceptibilities of M. tuberculosis H37Rv, M. bovis BCG Tice,
M. avium and M. abscessus GZ002 to TSR were performed using
mid log phase high titer (>107 CFU/plate) cultures on 0, 2, 20,
and 100 µg/mL Middle Brook 7H11 TSR agar plates.
Minimum inhibition concentration (MIC) was defined as
the lowest concentration of a drug inhibiting 99% of bacterial
growth (Zhang et al., 2010). The MIC values for wild-type
and recombinant mycobacteria were detected on Middle Brook
7H11 agar plates containing different concentrations of TSR
(0–160 µg/mL) and GEN (0–100 µg/mL).
General DNA Techniques
Polymerase chain reaction (PCR) amplification reactions were
performed with pfu DNA polymerase (Takara). The PCR
products and plasmids were analyzed by electrophoresis in
agarose gels and purified using a DNA gel extraction kit (Magen,
China). Plasmids were also extracted and purified using kits from
the same company. Purified PCR products and plasmids were
sequenced (BGI, Shenzhen, China). The aacC1 gene (0.543 kb)
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TABLE 1 | List of plasmids and strains used in the study.
Strains/plasmids Relevant characteristic(s)a Source or reference
Escherichia coli DH5α General-purpose cloning strain; F− (φ80d lacZ1M15) 1D (lacZYA-argF ) U169 deoR recA1 endA1
hsdR17 glnV44 thi-1 gyrA96 relA
Hanahan, 1983
Mycobacterium
smegmatis mc2155
Highly transformable derivative of ATCCa 607 Snapper et al., 1990
M. tuberculosis H37Rv Widely used virulent laboratory M. tuberculosis strain, ATCCa 27294 Zhang et al., 2010
M. tuberculosis H37Ra Selectable marker-free autoluminescent M. tuberculosis H37Ra Yang et al., 2015
M. bovis Tice The live attenuated TB vaccine Zhang et al., 2010
M. avium Clinical isolate from Guangzhou chest hospital and verified by PCR Guo et al., 2016
M. abscessus GZ002 Clinical isolate from Guangzhou chest hospital with profile of lysine acetylation that shares similarities
with M. tuberculosis
Guo et al., 2016
p60luxN p60lux truncated with 18 bp at the 3− of hsp60 promoter to remove the six amino acid for fusion
expression and introduced at the ATG of NdeI as the initiation codon
Liu et al., 2015
p60Gm 0.543 kb aacC1–gentamicin-(3)-N-acetyltransferase from Pseudomonas aeruginosa plasmid R1033
transposon Tn1696 cloned adjacent to mycobacterial hsp60 promoter into the NdeI–PstI sites of
p60luxN, episomal
This study
p60GTE 0.8 kb tsr fragment cloned adjacent to aacC1 on the PstI–XbaI sites of p60Gm (hsp60–aacC1–tsr
cassette), episomal
This study
pUCDHmke= pTYdHm AmpR, HygR, E. coli high copy number cloning vector bearing the dif-HYG-dif, episomal Yang et al., 2014
pUCDGT dif- hsp60–aacC1–tsr–dif cassette cloned into the XbaI site of pTYdHm replacing the HygR gene,
episomal
This study
pMH94 pUC119 carrying KANr from Tn9O3 and attp-int cassette from L5 mycobacteriophage at SalI-SalI,
integrative
Lee et al., 1991
p60GTI dif- hsp60–aacC1–tsr–dif cassette cloned into the HindIII site of plasmid pMH94 replacing the KmR,
E. coli–mycobacterial shuttle vector bearing the attP:int fragment, integrative
This study
pPR27 E. coli–mycobacterial shuttle vector, oriM, tempS, sacB, xylE, GENR episomal Pelicic et al., 1997
pIJ6902 AmR, TSRR integrative Huang et al., 2005
aAbbreviations for resistance phenotypes: AmpR, ampicillin; KmR, kanamycin; HygR, hygromycin; GmR, gentamicin; AmR, apramycin; TSRR, thiostrepton; tempS,
temperature sensitivity; ATCC, The American Type Culture Collection; dif, the action site of the XerCD recombinase.
TABLE 2 | List of DNA primers used in the study.
Primers Nucleotide sequence (5′-3′) with enzyme sites
underlined
Restriction
enzyme
Gm-f GGGAATTCAAGCTTCATATGCCGAGAGCTTGGCACC NdeI
Gm-r CCCAAGCTTCTGCAGTTAGGTGGCGGTACTTGG PstI
Tsr-f CGGCTGCAGATGACTGAGTTGGACAC PstI
Tsr-r CCCAAGCTTTCTAGATTATCGGTTGGCCGCG XbaI
Tsr-f1 GAGTAAGCCGATAAGCGACA
Tsr-r1 TCGAGACTTGACATAATGTC
Start and stop codon italicized, enzyme site underlined.
was amplified from plasmid pPR27 (Table 1) using primers Gm-f
and Gm-r (Table 2) while the 0.8 kb tsr gene was amplified from
plasmid pIJ6902 (Table 1) using primers Tsr-f and Tsr-r (Table 2).
Construction of Shuttle Vector
Containing tsr + aacC1 Resistance
Genes
To construct a vector bearing tsr+aacC1, we arranged the genes
into a cassette under the control of the M. tuberculosis hsp60
promoter (Figure 1) in plasmid p60LuxN (Liu et al., 2015)
intending the aacC1 gene to be used for selection in E. coli
and M. smegmatis mc2155 and the tsr gene to be used in
M. tuberculosis andM. bovisBCG. The aacC1was cloned adjacent
to the hsp60 promoter into the NdeI-PstI sites of p60LuxN
resulting in plasmid p60Gm. The tsr gene was cloned into the
PstI-HindIII sites of plasmid p60Gm to get E. coli-mycobacteria
shuttle plasmid p60GTE bearing hsp60-aacC1-tsr cassette.
Construction of dif-hsp60-aacC1-tsr-dif
Cassette
The hsp60-aacC1-tsr cassette was excised with XbaI from plasmid
p60GTE and cloned into the XbaI sites of E. coli pUCDHmke
derived from pTYdHm (Yang et al., 2014) plasmid (Table 1)
bearing a dif -HYG-dif cassette replacing hyg gene and
creating plasmid pUCDGT. The dif-hsp60-aacC1-tsr-dif cassette
(Figure 1) was excised by HindIII from pUCDGT and cloned
into the integrative plasmid pMH94 (Table 1) replacing the KAN
resistance gene and creating plasmid p60GTI.
Transformation
Plasmids p60GTE and p60GTI were used. M. smegmatis was
transformed as previously described (Snapper et al., 1990), while
M. tuberculosis and M. bovis BCG were transformed as previously
described (Wards and Collins, 1996; Yang et al., 2015) with
some modifications. The competent M. tuberculosis and M. bovis
BCG cells were first incubated at 37◦C for 10 min before
electroporation and transformation was performed at room
temperature. Transformants were selected on plates containing
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FIGURE 1 | Scheme of vector construction. The Escherichia coli-mycobacterial plasmid p60GTE was derived by inserting aacC1 and tsr fragments next to the
mycobacterial hsp60 promoter. The hsp60-aacC1-tsr cassette was excised and inserted on to the XbaI sites of pUCDHmke bearing the dif sequences. The
dif-hsp60-aacC1-tsr-dif cassette was excised and inserted on the Hind III sites of plasmid pMH94. attP, mycobacteriophage L5 attachment site; int, integrase gene;
oriE, origin region of E. coli; oriM, thermosensitive origin region of mycobacteria; KanR, KAN resistance gene, dif : the putative MTB dif sequence. Useful enzyme
sites: NdeI; HindIII; PstI and XbaI.
TABLE 3 | Minimum inhibition concentrations (MICs) of TSR for wild-type
and recombinant mycobacteria.
M. tuberculosis and M. bovis BCG
Tice strains
MIC (µg/mL)
M. tuberculosis H37Rv 0.125
M. tuberculosis H37Rv::p60GTE >800
M. tuberculosis H37Rv::p60GTI >800
M. bovis BCG Tice 0.25
M. bovis BCG Tice::p60GTE 160
M. bovis BCG Tice::p60GTI 160
TSR (5 and 10µg/mL) for both M. bovis BCG and M. tuberculosis
while containing GEN (5 µg/mL) for M. smegmatis. Individual
transformant colonies of three independent transformations
were counted to determine the transformation frequencies per
microgram of DNA and tested by PCR with primers Tsr-f and
Tsr-r.
Analysis of Unmarked Recombinant
M. tuberculosis and M. bovis BCG
Transformants
Unmarked recombinant transformants were analyzed according
to Yang et al. (2014). Briefly, PCR verified TSR-resistant single
TABLE 4 | Transformation frequency for M. bovis BCG Tice and
M. tuberculosis H37Rv using TSR and M. smegmatis mc2155 using GEN
as a selection marker.
Transformation frequency for:
Plasmids M. smegmatis M. bovis M. tuberculosis
mc2155 BCG-Tice H37Rv
p60GTE 2.8 × 103 4.3 × 103 1.26 × 104
p60GTI 1.5 × 103 2 × 102 3.5 × 103
Frequency represent the number of transformants per microgram of DNA.
Results are expressed as the mean number of colonies in triplicate experiments.
TABLE 5 | Minimum inhibition concentrations of GEN for wild-type and
recombinant M. smegmatis mc2155.
M. smegmatis mc2155 MIC (µg/mL)
M. smegmatis mc2155 2.5
M. smegmatis mc2155::p60GTE 100
M. smegmatis mc2155::p60GTI 100
p60GTI colonies were individually cultured in 7H9 media
to late log phase (OD600 = 0.8–1.0) without selection to
allow excision of the dif-hsp60-aacC1-tsr-dif cassette by the
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endogenous mycobacteria XerC and XerD. Ten-fold serial
dilutions of bacterial culture were spread on plain agar plates.
The colonies were picked and replica streaked on both plain
and 10 µg/mL TSR-containing 7H11 plates. The TSR-sensitive
colonies were verified further by PCR amplification of the 1.9 kb
cassette using primers Tsr-f1 and Tsr-r1 (Table 2) and the shorter
PCR products (∼0.5 kb) bearing one single dif sequence were
confirmed by sequencing.
RESULTS AND DISCUSSION
TSR as a Potential Selection Antibiotic
against Mycobacteria
We first tested the potential use of TSR as a selective antibiotic
against mycobacteria. Using liquid culture autoluminescent
M. tuberculosis H37Ra, we tested different TSR concentrations
up to 10 µg/mL and the relative light units (RLUs) declined
sharply within 2 days and continuously till the end of the assay,
while those of blank control rose steadily (MIClux = 0.05 µM,
∼ = 0.08 µg/mL). Additional susceptibility testing on
2–50 µg/mL 7H11 TSR plates of M. tuberculosis and M.
bovis BCG Tice yielded complete growth inhibition while we
observed complete insensitivity even on 7H11 plates containing
100 µg/mL TSR for M. avium, M. abscessus GZ002 and
M. smegmatis mc2155 illustrating the unsuitability of TSR
as their selection antibiotic. We detected the TSR MICs of
M. tuberculosis H37Rv strain and M. bovis BCG Tice as 0.125 and
0.25 µg/mL (Table 3) similar to the 0.08 µM (∼0.133 µg/mL to
M. tuberculosis H37Rv) reported by Lougheed et al. (2009) and
no mutant resistant colonies were observed.
Construction of Plasmids p60GTE and
p60GTI, Their Transformation
Frequencies and MICs in Respective
Recombinant Strains
We set out to construct two plasmids expressing tsr and aacC1
genes in both E. coli and mycobacteria. We constructed episomal
and integrative E. coli-mycobacterial shuttle plasmids bearing
the mycobacterial hsp60 promoter, aacC1 and the tsr gene
flanked by dif sequences (Figure 1). Both antibiotic resistance
markers, the streptomyces TSR resistance gene, tsr, and the
Pseudomonas aeruginosa GEN resistance gene, aacC1, worked in
mycobacterial transformants. TSR resistance is not a selectable
marker in E. coli due to outer membrane exclusion of TSR
by gram-negative bacteria (Gale et al., 1981). To circumvent
this, we used GEN for selection in E. coli and supplemented
the media with chloramphenicol 170 µg/mL to increase the
plasmid copy number. The transformation frequency for H37Rv
and M. bovis BCG overexpressed with the episomal plasmid
p60GTE were 1.26 × 104 and 4.3 × 103 CFUs and 3.5 × 103 and
2 × 102 CFUs, respectively, with the integrative plasmid p60GTI
on TSR 5 µg/mL (Table 4). Both H37Rv and M. bovis BCG
recombinant strains increased the MICs by >300-fold (Table 3)
while M. smegmatis mc2155 strains increased the MICs by 40-fold
(Table 5).
The loss of the tsr marker gene verified by PCR, yielded
∼0.5 kb products confirmed by sequencing to bear one dif
sequence as expected, from 12 and 20 randomly selected
recombinant p60GTI containing M. tuberculosis H37Rv and
M. bovis BCG colonies. We found that five of each recombinant
strain had lost the tsr gene which should be excised by
the endogenous mycobacterial recombinase XerCD system
expressed by XerC and XerD genes recognizing the dif cassette
(Cascioferro et al., 2010; Yang et al., 2014), resulting in selectable
marker-free colonies.
Our TSR MICs results concurs with the antimicrobial
bactericidal activity reported by others (Vermeulen and Wu,
2004; Lougheed et al., 2009), and to the best of our knowledge this
is the first report showing the use of TSR resistance as putative
selective marker for gene transfer in mycobacteria.
CONCLUSION
We have successfully constructed a cassette containing tsr
and aacC1 genes flanked by dif sequences for selection in
mycobacteria and demonstrated the potential of this cassette for
use as a mycobacteria selection marker in M. tuberculosis and
M. bovis BCG. The novelty of this work is the introduction and
expression of genes in a new cassette and verified by raising
of resistance in the corresponding host cells. The new reliable
selection marker comes in handy for M. tuberculosis genetic
manipulation studies and is a new tool for efficient construction
of selection-marker free recombinant strains.
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